Fig. 3From: The small vesicular culprits: the investigation of extracellular vesicles as new targets for cancer treatmentSchematic of EV-targeting therapy. Intercellular transfer of the EV cargo contributes to cancer development, so reducing EV transfer will provide new therapeutic strategies. Inhibition of EV production, elimination of circulating EVs and disruption of EV absorption will be main strategiesBack to article page